Alivus Life Sciences Limited has informed the Exchange regarding Notice of Postal Ballot
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences Limited (formerly Glenmark Life Sciences) has issued a postal ballot notice seeking shareholder approval for two special resolutions. The first resolution seeks the re-appointment of Mrs. Manju Agarwal (DIN 06921105) as an Independent Director for a second term of 5 years from October 30, 2025 to October 29, 2030. She is a former SBI official with 34 years of banking experience and serves on boards of several listed companies including Polycab, Gulf Oil Lubricants, and Hinduja Leyland Finance. The second resolution seeks the re-appointment of Mr. Taruvai Laxminarayanan Easwar (DIN 03135959) as an Independent Director for a second term of 5 years from January 8, 2026 to January 7, 2031. He is an IIT Kanpur alumnus and former President of Operations at Aurobindo Pharma, currently advising BCG. E-voting runs from June 25, 2025 to July 24, 2025, with results expected by July 26, 2025.
This is a routine corporate governance exercise with no material financial impact. Both directors have strong attendance records (4/4 board meetings in FY25) and bring relevant industry and finance expertise, which is supportive of board continuity. Shareholders should review and vote during the e-voting window.